GlassScriptPhysician profile
Brian Mcnichols
NPI 1922495852
$3,438.08
in general payments reported to CMS, 2019-2025
13 companies · $508 in 2025
The $508 reported for 2025 was more than what 79% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $280 · 2022: $315 · 2023: $854 · 2024: $1,481 · 2025: $508.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,264 · Travel and Lodging: $579.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,263.85 |
| Travel and Lodging | $578.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,539.36 | 2021-2024 | Onyx Frontier, Symplicity G3, Selectsecure |
| Inari Medical, INC. | $686.22 | 2023-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Novartis Pharmaceuticals Corporation | $322.17 | 2022-2024 | |
| Stryker Corporation | $257.18 | 2025 | Artix Mt, Clottriever Bold Catheter, Ct Thrombectomy System Kit |
| Boston Scientific Corporation | $242.28 | 2022-2024 | Avvigo Guidance System |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $160.85 | 2022-2023 | Lifevest |
| Alnylam Pharmaceuticals INC. | $56.81 | 2024-2025 | Onpattro |
| Pfizer INC. | $49.49 | 2023 | |
| Novo Nordisk INC | $38.69 | 2023 | Rybelsus, Ozempic |
| Daiichi Sankyo INC. | $27.40 | 2024 | Injectafer |
| Shockwave Medical, INC | $21.94 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $19.19 | 2022 | |
| Amgen INC. | $16.50 | 2023 | Repatha |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Mcnichols listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.